Institut Paoli-Calmettes Cancer Centre
- Address
- 232 Boulevard De Sainte Marguerite, Bp 156, 13009 Marseille, France
Institut Paoli-Calmettes Cancer Centre
Institut Paoli-Calmettes Cancer Centre is a leading comprehensive cancer research institution specializing in innovative therapeutic approaches for hematological malignancies and urological cancers. The center demonstrates expertise in conducting complex international clinical trials that evaluate novel treatment modalities and comparative effectiveness studies across diverse oncological conditions.
- Myeloproliferative neoplasms including polycythemia vera and risk assessment for disease transformation
- Advanced photodynamic therapy approaches for urological malignancies
- Upper tract urothelial carcinoma treatment strategies
The center's research portfolio encompasses both targeted molecular therapies for blood disorders and vascular-targeted photodynamic therapy (VTP) for solid tumors. Their clinical trials program focuses on evaluating long-term outcomes including thrombotic complications, hemorrhagic events, and disease transformation in polycythemia vera, as well as innovative organ-preserving treatments for low-grade upper tract urothelial cancer that offer alternatives to traditional surgical interventions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 26 therapeutic areas and 15 of 471 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 455 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Institut Paoli-Calmettes Cancer Centre
lock Showing 1 of 480 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| "CUPCAKE": Early detection of triple negative breast cancer relapse: a clinical utility trial | Institut Curie | Phase II | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 471 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Paclitaxel | 48 | Unknown | 2016-01-11 | 2026-07-10 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.